News

Heart failure is an insidious disease. Its symptoms can be vague—including shortness of breath, swelling of the ankles and fatigue. Too often, patients and family doctors miss the warning signs entirely, explained Peter Liu, MD, Chief Scientific Officer and Vice President of Research at the

A device about the size of a smartphone is enabling cardiologists to generate images of patients’ hearts at the point of care, enabling them to make more informed diagnoses and even intervene earlier. The result? Improved care and outcomes, and possibly even reduced health care costs. The device is

Arrhythmias — disturbances of the heart’s normal rhythm—affect more than 1.5 million Canadians and can impact a person’s health and well-being in a variety of ways. Sudden cardiac death caused by an arrhythmia kills 40,000 people every year. An estimated 350,000 Canadians are living with atrial

Hospitalization for pneumonia is a significant risk factor for cardiovascular disease (CVD) in middle-aged and older adults with no history of heart disease, according to a study recently published in the Journal of the American Medical Association. Presenting his findings at the University of

In October, a crane carefully lowered the University of Ottawa Heart Institute’s first dedicated magnetic resonance imaging (MRI) scanner into a narrow access way so that it could be rolled through the exterior wall of the building and into position. By early December, the new MRI facility was fully

Heart disease is different for women, and that difference is borne out in almost every aspect of the disease: the factors that lead to it, symptoms, diagnosis, treatment and even risk of death. In fact, heart disease kills more women worldwide than all cancers, tuberculosis, AIDS and malaria

Cardiovascular prevention and rehabilitation underwent extensive change in the 20th century and continues to evolve rapidly. Andrew Pipe, MD, in his Terry Kavanagh Lecture at the 2014 Canadian Cardiovascular Congress, outlined a vision for "CVD Prevention and Rehabilitation in the 21st Century." To

While modern medicine is heavily dependent on sophisticated technologies to diagnose and treat disease, health care generally lags behind other sectors in adopting advances in information technology. A number of presentations at the 2014 Canadian Cardiovascular Congress looked at ways in which

More than half a million Canadians are living with heart failure and another 50,000 join their ranks each year. The standard treatment for heart failure has not changed for quite some time. Now, a new drug—so new that it’s identified only as LCZ696—is generating interest among cardiologists and

Until the new oral anticoagulant (NOAC) drugs became available, beginning in 2009, warfarin was the workhorse for managing stroke risk in patients with atrial fibrillation. In his Research Achievement Award presentation, Stuart Connolly, MD, of McMaster University in Hamilton, Ont., provided a